Boule Diagnostics AB is a high-risk Healthcare company based in Sweden with an ESG score of 30.4. Specializing in blood diagnostics, Boule Diagnostics AB develops, manufactures, and markets instruments and consumables for hospitals, clinics, and laboratories. With a focus on the decentralized market segment, the company operates in Sweden, USA, and China.